Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Sale
SEC Form 4 Filing
Daveen Chopra, CVP at Edwards Lifesciences, reported the sale of 1,250 shares of common stock on August 20, 2024.
Summary
- On August 20, 2024, Daveen Chopra, CVP of TMTT at Edwards Lifesciences Corp, sold 1,250 shares of common stock.
- The sale price was $69.9501 per share.
- Following the transaction, Chopra directly owns 29,333 shares of Edwards Lifesciences Corp.
- The transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 5
Explanation: This is a routine disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Executive stock sales are a common occurrence and can be for various personal financial planning reasons. It's important to consider the context of overall insider trading activity and company performance when evaluating the significance of this sale.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although it is a common practice.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.